Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36076 - 36100 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	PPARD	5467	downregulated	Doxorubicin results in decreased expression of PPARD mRNA	6p21.31	A22426
Doxorubicin	Approved Investigational	PPP1R3A	5506	downregulated	Doxorubicin results in decreased expression of PPP1R3A mRNA	7q31.1	A21904
Doxorubicin	Approved Investigational	PPT2	9374	upregulated	Doxorubicin results in increased expression of PPT2 mRNA	6p21.32	A22426
Doxorubicin	Approved Investigational	PRDM16	63976	downregulated	Doxorubicin results in decreased expression of PRDM16 mRNA	1p36.32	A21904
Doxorubicin	Approved Investigational	PRKACA	5566	upregulated	Doxorubicin results in increased expression of PRKACA mRNA	19p13.1	A22426
Doxorubicin	Approved Investigational	PRKX	5613	upregulated	Doxorubicin results in increased expression of PRKX mRNA	Xp22.33	A21904
Doxorubicin	Approved Investigational	PRL	5617	upregulated	Doxorubicin results in increased expression of PRL mRNA	6p22.3	A22472
Doxorubicin	Approved Investigational	PROCR	10544	downregulated	Doxorubicin results in decreased expression of PROCR mRNA	20q11.22	A22473
Doxorubicin	Approved Investigational	PTGS2	5743	downregulated	Doxorubicin results in decreased expression of PTGS2 mRNA	1q31.1	A22430 A22435
Doxorubicin	Approved Investigational	PTGS2	5743	upregulated	Doxorubicin results in increased expression of PTGS2 mRNA	1q31.1	A22474 A22422
Doxorubicin	Approved Investigational	PTPN13	5783	upregulated	Doxorubicin results in increased expression of PTPN13 mRNA	4q21.3	A21894
Doxorubicin	Approved Investigational	PTTG1	9232	downregulated	Doxorubicin results in decreased expression of PTTG1 mRNA	5q33.3	A22430
Doxorubicin	Approved Investigational	PYGM	5837	downregulated	Doxorubicin results in decreased expression of PYGM mRNA	11q13.1	A21904
Doxorubicin	Approved Investigational	RAD51	5888	downregulated	Doxorubicin results in decreased expression of RAD51 mRNA	15q15.1	A21498
Doxorubicin	Approved Investigational	RAD51C	5889	upregulated	Doxorubicin results in increased expression of RAD51C mRNA	17q22	A22456
Doxorubicin	Approved Investigational	RARB	5915	upregulated	Doxorubicin results in increased expression of RARB mRNA alternative form	3p24.2	A20667
Doxorubicin	Approved Investigational	RBPMS	11030	upregulated	Doxorubicin results in increased expression of RBPMS mRNA	8p12	A22426
Doxorubicin	Approved Investigational	REL	5966	downregulated	Doxorubicin results in decreased expression of REL mRNA	2p16.1	A22426
Doxorubicin	Approved Investigational	RELN	5649	upregulated	Doxorubicin results in increased expression of RELN mRNA	7q22.1	A20440
Doxorubicin	Approved Investigational	RGS13	6003	downregulated	Doxorubicin results in decreased expression of RGS13 mRNA	1q31.2	A22426
Doxorubicin	Approved Investigational	RHCG	51458	upregulated	Doxorubicin results in increased expression of RHCG mRNA	15q26.1	A22426
Doxorubicin	Approved Investigational	RRM2B	50484	upregulated	Doxorubicin results in increased expression of RRM2B mRNA	8q22.3	A21622
Doxorubicin	Approved Investigational	RYR2	6262	downregulated	Doxorubicin results in decreased expression of RYR2 mRNA	1q43	A21904
Doxorubicin	Approved Investigational	S100A8	6279	upregulated	Doxorubicin results in increased expression of S100A8 mRNA	1q21.3	A20888
Doxorubicin	Approved Investigational	SCN2B	6327	downregulated	Doxorubicin results in decreased expression of SCN2B mRNA	11q23.3	A21904

Displaying entries 36076 - 36100 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability